Pharmaceutical Industry Information Portal

HomeTagsPromomed Group

All posts by tag

Promomed Group

Efficacy of Areplivir (favipiravir) in the treatment of COVID-19 discussed at the 16th Russian Congress of Internal Medicine

On the first day of the 16th Russian Congress of Internal Medicine, Promomed Group organized a satellite symposium «Always on the same side against...

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

Revenue of PROMOMED DM LLC for 9 months of 2021 increased by 194.74% and amounted to RUB 13.25 bln.

PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS). According to the results of 9...

Promomed Group received approval for the first drug in its portfolio for treatment of HIV infection

Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...

Petr Bely: «State support of new markets will help to warm up domestic pharma»

«Pharmaceutical industry can and should be financially self-sufficient,» said Peter Bely, Chairman of the Board of Directors of Promomed Group at the «Strategy Implementation...

The second joint laboratory of Promomed Group and Ogarev MSU is now officially opened

On September 30, with the support of Biokhimik JSC of Promomed Group, the scientific and educational laboratory for the synthesis of active pharmaceutical substances...
spot_img

Expert Articles

spot_img